Using myelin water imaging to link underlying pathology to clinical function in multiple sclerosis: A scoping review

被引:7
作者
Edwards, Erin M. [1 ]
Wu, Wendy [2 ]
Fritz, Nora E. [1 ,3 ,4 ]
机构
[1] Wayne State Univ, Sch Med, Dept Psychiat, Translat Neurosci Program, Detroit, MI USA
[2] Wayne State Univ, Shiffman Med Lib, Detroit, MI USA
[3] Wayne State Univ, Dept Hlth Care Sci, Detroit, MI USA
[4] Wayne State Univ, Dept Neurol, Detroit, MI USA
关键词
Myelin water imaging; Multiple Sclerosis; Disability; Walking; Cognition; Rehabilitation response; COGNITIVE IMPAIRMENT; CORPUS-CALLOSUM; BRAIN; DIFFUSION; WHITE; MRI; INTEGRITY; IMPACT; DAMAGE; T-2;
D O I
10.1016/j.msard.2022.103646
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: Multiple sclerosis (MS) symptoms and pathology are heterogenous and complex. Identifying links between MS-related pathology (i.e., myelin damage) and associated clinical symptoms is critical for developing targeted therapeutics. Conventional MRI, commonly used for MS diagnosis and disease monitoring, lacks specificity with functional performance. Myelin water imaging (MWI) demonstrates increased specificity to myelin and is viewed as the gold standard for imaging myelin content in vivo. Yet, there is a paucity of MWI studies in MS and only a limited number also examine clinical function. Thus, it remains unknown whether MWI corresponds to functional performance in MS. This scoping review aimed to examine relations between MWI and functional domains relevant to MS to inform and guide future research. Methods: Seven databases were searched from their inception to September 1, 2021. Studies of adults with MS that included both brain MWI and either a measure of physical function, a measure of cognitive function, or a measure of disease severity were included. Thirteen studies (11 observational, 2 intervention) met the inclusion criteria. Results: The most commonly investigated MWI metric is the myelin water fraction (MWF). Persons with MS demonstrated markedly decreased MWF compared to healthy controls globally and across brain regions of interest (ROIs). Decreased MWF was associated with higher disability, worse motor and cognitive performance and decreased intervention response. Only five studies examined structure-function relationships in brain areas related to walking and cognitive function and only six studies extracted MWI metrics from explicit brain ROIs. Conclusions: MWI is a neuroimaging technique with increased specificity to myelin and offers greater insight to MS-driven pathology and its clinical manifestations, including motor and cognitive dysfunction and rehabilitation response. This scoping review identified critical gaps in MWI research in MS to offer future perspectives including ROI-based studies, inclusion of multi-domain functional assessment and examining MWI to provide evidence of neuroplasticity following training.
引用
收藏
页数:10
相关论文
共 55 条
  • [1] 'Scoping the scope' of a cochrane review
    Armstrong, Rebecca
    Hall, Belinda J.
    Doyle, Jodie
    Waters, Elizabeth
    [J]. JOURNAL OF PUBLIC HEALTH, 2011, 33 (01) : 147 - 150
  • [2] MRI in multiple sclerosis: correlation with expanded disability status scale (EDSS)
    Barkhof, F
    [J]. MULTIPLE SCLEROSIS JOURNAL, 1999, 5 (04) : 283 - 286
  • [3] MR DIFFUSION TENSOR SPECTROSCOPY AND IMAGING
    BASSER, PJ
    MATTIELLO, J
    LEBIHAN, D
    [J]. BIOPHYSICAL JOURNAL, 1994, 66 (01) : 259 - 267
  • [4] Data fusion detects consistent relations between non-lesional white matter myelin, executive function, and clinical characteristics in multiple sclerosis
    Baumeister, Tobias R.
    Lin, Sue-Jin
    Vavasour, Irene
    Kolind, Shannon
    Kosaka, Brenda
    Li, David K. B.
    Traboulsee, Anthony
    MacKay, Alex
    McKeown, Martin J.
    [J]. NEUROIMAGE-CLINICAL, 2019, 24
  • [5] The basis of anisotropic water diffusion in the nervous system - a technical review
    Beaulieu, C
    [J]. NMR IN BIOMEDICINE, 2002, 15 (7-8) : 435 - 455
  • [6] Alemtuzumab for patients with relapsing multiple sclerosis after disease-modifying therapy: a randomised controlled phase 3 trial
    Coles, Alasdair J.
    Twyman, Cary L.
    Arnold, Douglas L.
    Cohen, Jeffrey A.
    Confavreux, Christian
    Fox, Edward J.
    Hartung, Hans-Peter
    Havrdova, Eva
    Selmaj, Krzysztof W.
    Weiner, Howard L.
    Miller, Tamara
    Fisher, Elizabeth
    Sandbrink, Rupert
    Lake, Stephen L.
    Margolin, David H.
    Oyuela, Pedro
    Panzara, Michael A.
    Compston, D. Alastair S.
    [J]. LANCET, 2012, 380 (9856) : 1829 - 1839
  • [7] Disconnection as a mechanism for cognitive dysfunction in multiple sclerosis
    Dineen, R. A.
    Vilisaar, J.
    Hlinka, J.
    Bradshaw, C. M.
    Morgan, P. S.
    Constantinescu, C. S.
    Auer, D. P.
    [J]. BRAIN, 2009, 132 : 239 - 249
  • [8] Mechanisms of neuronal dysfunction and degeneration in multiple sclerosis
    Dutta, Ranjan
    Trapp, Bruce D.
    [J]. PROGRESS IN NEUROBIOLOGY, 2011, 93 (01) : 1 - 12
  • [9] An atlas for human brain myelin content throughout the adult life span
    Dvorak, Adam V.
    Swift-LaPointe, Taylor
    Vavasour, Irene M.
    Lee, Lisa Eunyoung
    Abel, Shawna
    Russell-Schulz, Bretta
    Graf, Carina
    Wurl, Anika
    Liu, Hanwen
    Laule, Cornelia
    Li, David K. B.
    Traboulsee, Anthony
    Tam, Roger
    Boyd, Lara A.
    MacKay, Alex L.
    Kolind, Shannon H.
    [J]. SCIENTIFIC REPORTS, 2021, 11 (01)
  • [10] Backward walking sensitively detects fallers in persons with multiple sclerosis
    Edwards, Erin M.
    Daugherty, Ana M.
    Nitta, Manon
    Atalla, Mareena
    Fritz, Nora E.
    [J]. MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2020, 45